Wai Yuen Tong Medicine Holdings Limited provided consolidated earnings guidance for the six months ended 30 September 2023. The group is expected to record a turnaround from a loss attributable to owners of the parent for the six months ended 30 September 2022 of approximately HKD 53.4 million to a profit attributable to owners of the parent of not more than approximately HKD 20.0 million for the six months ended 30 September 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 HKD | 0.00% | 0.00% | -42.50% |
1st Jan change | Capi. | |
---|---|---|
-42.50% | 33.12M | |
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |
- Stock Market
- Equities
- 897 Stock
- News Wai Yuen Tong Medicine Holdings Limited
- Wai Yuen Tong Medicine Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 September 2023